Stay updated on IBI310 + Sintilimab in dMMR/MSI-H CRC Clinical Trial
Sign up to get notified when there's something new on the IBI310 + Sintilimab in dMMR/MSI-H CRC Clinical Trial page.

Latest updates to the IBI310 + Sintilimab in dMMR/MSI-H CRC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision label 'Revision: v3.4.2' was added and an operating-status notice about government funding was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check21 days agoChange DetectedAdded a government funding status notice and updated the site revision to 3.4.1 (replacing the previous 3.4.0).SummaryDifference0.9%

- Check28 days agoChange DetectedThe Record History page now includes a 'Show glossary' option and color-coded change highlights (green for additions, red for deletions) with explanatory text, and the revision tag has been updated to v3.4.0 (replacing v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check42 days agoChange DetectedA new revision label (v3.3.4) appears in the Record History replacing the previous v3.3.3; this is a metadata update with no impact on study content, and to avoid alerts for small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedThe changes are minor site-wide updates to the footer/record history, including an added Revision: v3.3.3 and removal of HHS Vulnerability Disclosure and Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check92 days agoChange DetectedRecord history shows a new revision entry v3.3.2 and removal of v3.2.0. This update pertains to page versioning rather than changes to the study data.SummaryDifference0.1%

Stay in the know with updates to IBI310 + Sintilimab in dMMR/MSI-H CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IBI310 + Sintilimab in dMMR/MSI-H CRC Clinical Trial page.